The Forest Pharmacy: When Habitat Loss Takes Away Nature’s Medicine Cabinet

When animals know what to eat when they are sick

A forest can look deceptively quiet.

Trees stand where they have stood for decades. Vines climb trunks. Elephants move through the understory. Birds call from the canopy. Insects disappear beneath leaves. Nothing about the landscape necessarily announces that a pharmacy is operating there.

Yet, for an animal living in that ecosystem, the forest is not simply a source of food.

It is a chemical landscape.

Every leaf, bark, root, fruit, seed, flower, resin, fungus, insect, mineral deposit and patch of soil can contain compounds that influence digestion, parasites, inflammation, immunity, microbes or other physiological processes. Some of these substances are nutritious. Some are toxic. Some are both, depending on dose and circumstance.

And some animals appear capable of selecting particular natural materials when their physiological condition changes.

This phenomenon is studied under the broad field of zoopharmacognosy the study of animals obtaining or using biologically active substances from their environment in ways that may help maintain health, prevent disease or respond to illness.

The subject challenges one of our most deeply human assumptions: that medicine begins when humans discover a chemical, isolate it, name it and put it into a bottle.

Perhaps medicine has a much older history.

Perhaps some of its earliest laboratories were forests.

And perhaps some of its earliest researchers were animals.

But this idea carries a much bigger conservation message than the fascinating behaviour itself.

If animals depend on particular plants, soils or insects for health, then destroying their habitat may mean destroying not only their food and shelter, but also their access to a natural health-care system.

That is a different way of understanding biodiversity loss.

We do not merely lose species.

We can lose biological knowledge, chemical diversity, ecological relationships and medicinal possibilities that may have evolved over millions of years.

The forest, in this sense, is not simply a pharmacy.

It is an enormous, living and largely uncatalogued pharmacological library.

Zoopharmacognosy: when behaviour becomes a medical clue

The word zoopharmacognosy combines roots referring to animals, drugs or medicines, and knowledge.

The concept is broader than the popular image of a sick animal deliberately eating a medicinal plant.

Animal medical behaviour can include consuming unusual plants, swallowing whole leaves, applying substances to wounds or skin, rubbing against particular materials, ingesting soil or clay, using insects or plant materials externally, and in some species providing potentially medicinal materials to other individuals.

Modern research has increasingly expanded the concept from self-medication to the broader idea of animal medication, because some animals appear to provide medicinal substances or behaviours to offspring or other members of their social group.

This distinction matters.

Self-medication means an animal appears to treat itself.

Allo-medication refers more broadly to one animal providing potentially medicinal treatment to another.

Kin medication involves relatives, while social medication can benefit members of a group or colony.

The discovery of such behaviours has forced scientists to reconsider the relationship between behaviour, ecology, physiology and disease.

But scientific caution is essential.

If an animal eats a plant while sick, that does not automatically prove the plant is medicine.

The plant might simply be part of its normal diet. It might contain nutrients. It might help digestion without treating the underlying disease. The animal may have learned the behaviour through social observation, or the apparent association may be coincidental.

Strong claims of self-medication therefore require multiple lines of evidence.

Researchers ideally want to know whether the behaviour is unusual, whether it occurs specifically during illness or elevated infection risk, whether the substance has biologically relevant activity, whether the behaviour changes disease or parasite burden, whether there is a physiological benefit, and whether the costs of consuming the substance make sense as an adaptive behaviour.

The most convincing studies therefore combine behavioural observation, ecology, veterinary or medical assessment, chemistry, microbiology, pharmacology and longitudinal evidence.

Zoopharmacognosy becomes scientifically powerful precisely when curiosity is followed by testing.

The chimpanzee clue: medicine hidden inside a meal

Among the best-known examples come from wild chimpanzees.

Chimpanzees have been observed swallowing certain rough, undigested leaves whole rather than chewing them like ordinary food. The behaviour has been associated with intestinal parasite removal because the leaves can physically interact with parasites or help alter their passage through the digestive tract.

Chimpanzees have also been observed consuming bitter plant material containing biologically active secondary compounds. One of the classic examples involves Vernonia amygdalina, whose chemistry has been investigated in relation to antiparasitic effects.

The important scientific lesson is not simply that chimpanzees “know medicine.”

It is that animal behaviour can identify unusual biological interactions that would otherwise be easy to overlook.

A botanist walking through a forest might catalogue hundreds of plant species.

A chimpanzee living there experiences the same vegetation differently.

It encounters the plants through taste, smell, physiological consequences, parasites, digestion and repeated experience.

For the chimpanzee, the forest is not a botanical collection.

It is an interactive chemical environment.

That difference in perspective can be scientifically valuable.

When medicine becomes culture

One of the most intriguing questions is how animals acquire medicinal behaviour.

Does an animal inherit an instinct to recognize a particular plant?

Does it learn through trial and error?

Does sickness create a physiological feedback loop that teaches the individual which substances provide relief?

Or does knowledge pass socially from experienced animals to younger ones?

The answer may be different for different species and behaviours.

Young animals observe mothers. Group members observe one another. Individuals may remember the consequences of consuming particular foods. Seasonal availability may create recurring opportunities to learn.

Over generations, such behaviours could become part of a population's behavioural repertoire.

This raises an extraordinary possibility.

Animal medicinal knowledge may sometimes have a cultural component.

If an old female elephant knows where a particular medicinal plant grows, and younger elephants follow her, then the disappearance of that experienced individual could potentially mean the disappearance of information that is not encoded in the animal's genes.

This gives conservation another dimension.

Protecting animals may mean protecting not only their bodies and habitats, but also the behavioural knowledge accumulated within their societies.

The elephant story has become even more remarkable

Elephants are especially interesting because they live in chemically diverse landscapes, have large home ranges, strong social structures and long lifespans.

A remarkable new case comes from the Mount Elgon region of Kenya, where research published in Scientific Reports in September 2026 documented Indigenous observations concerning possible elephant self-medication.

Researchers interviewed eight members of the local Sabaot community, including wildlife scouts, elders, guides and others with more than two decades of experience observing elephants.

The study documented reports involving 35 plant species from 23 families, as well as four types of soils, minerals or clays. Of the 39 natural resources recorded, local informants identified 34, about 87%, as having traditional medicinal uses for humans. Eight plant species were classified in the study's strongest behavioural category, involving plants reportedly sought by visibly sick elephants or administered to offspring for perceived health benefits.

Some accounts were particularly striking.

Mother elephants were reported to combine particular plant materials with milk before providing them to calves. Other observations involved unusual feeding behaviour, selective targeting of plants, seasonal or infrequent consumption, and elephants travelling specifically toward certain resources.

The study is important, but its language is equally important.

The researchers describe the behaviour as putative self-medication, not proven pharmacological treatment.

The evidence is based substantially on experienced local observations and ethnomedicinal knowledge, rather than controlled experiments demonstrating that a specific plant cures a particular elephant disease.

That distinction is not a weakness.

It is good science.

The study demonstrates how Indigenous ecological knowledge and animal behaviour can identify promising research questions while also showing why laboratory, veterinary and ecological validation must follow.

The forest as a chemical library

Why might animals select certain plants?

Plants cannot run away from herbivores, pathogens or environmental stress.

Instead, they have evolved chemistry.

Plants produce enormous diversity in secondary metabolites, compounds involved in defence, signalling, interactions with microbes, herbivores and other organisms.

These compounds can include alkaloids, terpenoids, phenolics, tannins, flavonoids, glycosides and many other chemical families.

From the plant's perspective, these substances may be weapons, shields, signals or ecological tools.

From an animal's perspective, the same compounds may sometimes influence parasites, microbes, inflammation, digestion or other physiological processes.

This creates a fascinating evolutionary intersection.

A compound evolved by a plant to defend itself does not have to have evolved “for medicine” to become pharmacologically useful to another species.

The medicinal effect can be an emergent property of ecological interaction.

That is one reason natural-product scientists continue to study biodiversity.

The forest is effectively a library of molecular structures, but unlike a conventional library, its books are alive, evolving and interacting with one another.

From animal behaviour to human medicine

The possibility that animal behaviour can guide drug discovery is one of the most scientifically exciting aspects of zoopharmacognosy.

Natural-product research has long used ecological information to identify promising organisms.

If an organism repeatedly uses a particular plant in an unusual context, especially around illness or parasite exposure, that behaviour can become a hypothesis for investigation.

The research pathway might look like this:

Animal observation → ecological context → species identification → plant-part identification → chemical analysis → bioassay → mechanism studies → toxicity testing → pharmacological evaluation → clinical research

At no stage should “the elephant eats it” become equivalent to “humans should take it.”

That would be scientifically and medically irresponsible.

Animal metabolism differs from human metabolism.

Dose matters.

Preparation matters.

Route of administration matters.

A substance tolerated by an elephant may be harmful to a human.

A plant that contains a useful molecule may also contain toxic compounds.

A traditional preparation may involve extraction methods that substantially change chemical composition.

Zoopharmacognosy therefore does not provide ready-made prescriptions.

It provides research leads.

Evolution as a laboratory

There is another reason animal behaviour matters.

Evolution has been conducting experiments for millions of years.

Plants and animals have been interacting through disease, predation, herbivory, competition and symbiosis for immense periods of time.

When an animal repeatedly consumes a particular plant under particular physiological conditions, researchers can ask whether this behaviour reflects an evolved relationship between animal physiology and plant chemistry.

The animal may be exploiting a chemical defence system that originally evolved for an entirely different purpose.

In this sense, ecological relationships can act as natural filters for biological activity.

Humans traditionally screen enormous numbers of compounds.

Animals, through their behaviour, may provide another kind of screening system.

They may effectively say:

“Pay attention to this organism.”

That does not prove the compound works.

But it tells researchers where a biologically interesting interaction may be occurring.

Not everything medicinal comes from plants

The phrase “forest pharmacy” should not be interpreted as “plant pharmacy.”

Animals use diverse natural materials.

Soils and clays may be consumed through geophagy.

Minerals may supply physiologically important elements.

Insects can be used in ways that may have defensive, antimicrobial or antiparasitic functions.

Fungi and microorganisms produce enormous chemical diversity.

Even animal-derived materials may have biological properties.

Research on insects has also expanded the field considerably. Recent reviews describe self-medication and behavioural immunity across diverse insect groups, including situations where animals adjust their behaviour or use environmental chemicals in response to pathogens.

This changes the conservation equation.

The medicinal landscape is not only the visible vegetation.

It includes the soil microbiome, fungi, insects, minerals, microorganisms and ecological interactions that make an ecosystem function.

Destroying a forest can therefore eliminate pharmacological possibilities that are invisible even to conventional biodiversity surveys.

The veterinary dimension: what animals may teach us about animal health

Zoopharmacognosy has implications beyond human medicine.

Domestic herbivores, including cattle, sheep and goats, can alter their food choices in response to physiological needs and parasite pressures. Research on herbivory and plant secondary compounds indicates that certain phytochemicals can have therapeutic or prophylactic effects at appropriate doses, while animals can learn associations between foods, physiological consequences and health.

This raises an important veterinary question:

Can livestock management provide animals with greater access to diverse, safe and appropriate plant choices that support health?

The concept is particularly relevant where gastrointestinal parasites create major problems.

Some plant secondary compounds can influence parasites, although they can also reduce feed intake or cause toxicity at excessive concentrations.

The objective therefore should not be to replace veterinary medicine with “medicinal plants.”

It is to understand whether dietary diversity and informed forage management can become one component of integrated animal health.

Research has already considered self-medication in domestic herbivores and the possibility that parasitized animals can select plant compounds associated with antiparasitic effects.

This could eventually contribute to integrated approaches combining:

• veterinary diagnosis,

• appropriate medicines,

• nutrition,

• pasture management,

• parasite monitoring,

• plant diversity,

• and animal behavioural knowledge.

Such an approach would be particularly relevant in sustainable livestock systems.

The danger of turning animal behaviour into a prescription

There is an important line that must never be crossed.

An elephant eating a bark does not mean humans should eat the bark.

A chimpanzee consuming a bitter plant does not mean the same preparation is safe for people.

A goat selecting a tannin-rich shrub does not mean the plant can replace an antiparasitic drug.

A dog eating grass does not automatically demonstrate medicinal intent.

The scientific value of zoopharmacognosy lies precisely in resisting simplistic interpretations.

The correct sequence is:

Observe first. Hypothesize second. Test third. Apply only after evidence establishes safety and efficacy.

This distinction protects both science and traditional knowledge from sensationalism.

Habitat loss can become pharmacological habitat loss

Now comes the conservation question.

Imagine a forest containing a rare medicinal plant.

If the forest disappears, the plant disappears.

That is ordinary habitat loss.

But imagine that an elephant population depends on that plant during particular health conditions.

Now the loss affects an animal's behavioural repertoire.

Imagine that an Indigenous community also knows the plant and uses it medicinally.

Now ecological knowledge is affected as well.

Imagine that the plant contains a previously unidentified molecule with antimicrobial or anti-inflammatory properties.

Now a potential future research resource has disappeared.

This is what might be called pharmacological habitat loss.

The term captures an underappreciated dimension of biodiversity destruction: ecosystems contain not only organisms but biological options.

Every lost species removes some part of the chemical and ecological possibility space.

Fragmentation can be as important as outright destruction

An animal does not necessarily need a medicinal plant to exist everywhere.

It may need to be able to reach it.

This makes habitat connectivity critical.

A medicinal plant could survive in a small isolated forest patch while an elephant population can no longer reach that patch safely.

The plant survives.

The animal survives.

Yet the ecological relationship has been broken.

This is why wildlife corridors can potentially function as more than movement routes.

They may preserve access to seasonal foods, mineral sites, nesting resources, water, shelter and potentially medicinal resources.

A corridor is therefore not simply a road between two protected areas.

It can be part of the ecological network that keeps behavioural choices possible.

The hidden cost of losing old animals

Long-lived social animals raise another conservation concern.

An old elephant, whale, primate or other experienced animal may possess information accumulated over decades.

Where are seasonal resources?

Which plants appear after rainfall?

Where are minerals available?

Which routes are safe?

Which locations should be avoided?

Which foods are associated with particular physiological conditions?

Such information may not be written anywhere.

It may be stored socially.

The loss of experienced individuals can therefore potentially create cultural erosion within animal populations.

For species whose knowledge is transmitted socially, conserving population structure and social continuity may be as important as conserving population numbers.

A population of animals is not merely a collection of individuals.

It can also be a repository of behavioural information.

Climate change may alter the forest pharmacy

Even if forests remain intact, climate change can alter the timing and chemistry of medicinal resources.

Plants respond to temperature, rainfall, drought, soil conditions and seasonal cues.

Their flowering, fruiting and leaf production can shift.

Chemical concentrations may also vary with environmental stress.

Animals may consequently face a new problem:

The resource still exists, but not when they need it.

This creates a potential phenological mismatch between animal health needs and resource availability.

An animal may traditionally travel to a particular plant during a particular season, only to encounter a changed landscape in which the plant flowers earlier, produces less biomass or becomes unavailable during periods of drought.

Climate change therefore threatens not only species distributions but also the timing of ecological interactions.

For zoopharmacognosy, this means that conservation cannot focus only on preserving species lists.

It must preserve functional relationships across seasons.

Overharvesting can empty the pharmacy from the inside

There is another paradox.

Once a plant becomes known for its medicinal properties, its value can become a threat.

Demand for medicinal plants can increase harvesting pressure.

Roots and bark are particularly vulnerable because harvesting can kill or severely damage the plant.

If humans and wildlife depend on the same resource, competition can intensify.

A plant may therefore disappear not because the forest is cleared, but because the biological resource is repeatedly extracted.

Sustainable medicinal-plant management requires cultivation where appropriate, regulated harvesting, regeneration studies, traceability, community participation and protection of wild populations.

Conservation cannot treat medicinal plants merely as commodities.

Their ecological role must remain part of the equation.

India: where biodiversity and traditional medicine meet

This story becomes particularly relevant in India.

India contains enormous biological and cultural diversity, and its traditional medical systems have developed alongside local ecosystems for centuries.

The Western Ghats are especially important.

Kerala's forests contain remarkable plant diversity, including large numbers of medicinally used species. Kerala Forest Department sources describe the state as having a major repository of medicinal plants and identify the Western Ghats as a globally important biodiversity region. Government biodiversity documentation also records extensive medicinal-plant diversity associated with Kerala's forest ecosystems.

This creates a powerful connection between zoopharmacognosy, ethnobotany and conservation in southern India.

The Western Ghats are not simply a collection of trees.

They are a landscape in which plants, elephants, primates, insects, fungi, soil organisms and human communities have interacted for generations.

A plant used by people may also be encountered by wildlife.

A plant selected by wildlife may attract human scientific interest.

Traditional knowledge may provide clues about preparation, plant parts and seasonality.

Animal behaviour may provide an independent ecological signal.

Scientific chemistry can then investigate the underlying compounds.

This creates a potential three-way knowledge interface:

Indigenous knowledge + animal behaviour + modern science

The objective should not be to decide that one knowledge system is superior to another.

The objective should be to create ethical and scientifically rigorous collaboration.

The Western Ghats as a living research landscape

Kerala is particularly relevant because its Western Ghats landscape contains high biological diversity, endemism and medicinal-plant resources.

Government sources identify the state's forests as an important repository of medicinal plants, while Kerala's biodiversity planning documents emphasize the extraordinary plant diversity and endemism of the Western Ghats.

For EcoVisionary, this creates a natural regional question:

What medicinal relationships between wildlife and plants in the Western Ghats have we not yet documented?

Asian elephants move through forests containing hundreds of plant species.

Primates select foods according to chemistry, nutrition and season.

Birds consume fruits and medicinally active materials.

Insects interact with plants and microorganisms at microscopic chemical scales.

Soils, minerals and fungi contribute additional dimensions.

The scientific record captures only a fraction of these interactions.

The absence of documentation should never be mistaken for the absence of behaviour.

Sometimes it simply means that nobody has looked carefully enough.

India’s biodiversity law: from biological resource to shared responsibility

The conservation of medicinal biodiversity also has a legal dimension.

India's biodiversity governance is built around the Biological Diversity Act, 2002, which was amended in 2023. The Biological Diversity Rules, 2024 subsequently superseded the earlier 2004 Rules, and the Biological Diversity (Access to Biological Resources and Knowledge Associated thereto and Fair and Equitable Sharing of Benefits) Regulations, 2025 now form part of the contemporary access-and-benefit-sharing framework.

For zoopharmacognosy, this matters because scientific research may involve biological resources and associated traditional knowledge.

Suppose researchers identify a plant because an Indigenous community has long recognized its medicinal use.

Suppose animal behaviour independently points toward the same plant.

Suppose laboratory research identifies a valuable compound.

The resulting knowledge cannot ethically be treated as if it emerged from nowhere.

Questions immediately arise:

Who provided the knowledge?

Who owns or holds associated knowledge?

Who participated in the research?

Who benefits from commercialization?

How should benefits return to communities?

How should sensitive ecological information be protected?

How can research avoid turning local knowledge into an extractive resource?

Access and benefit sharing exists precisely because biodiversity research has a history in which biological materials and knowledge have sometimes been separated from the communities and ecosystems that sustained them.

India's current biodiversity framework therefore becomes directly relevant to any serious future program connecting wildlife behaviour, traditional knowledge and natural-product discovery.

Indigenous knowledge is not merely a database

One of the greatest mistakes in biodiversity research is to treat Indigenous knowledge as a list of plant names.

A medicinal plant is not simply:

Species X = medicine.

Knowledge may include:

where it grows,

when it should be harvested,

which part should be used,

which age of plant is preferred,

how it should be prepared,

whether it should be combined with another substance,

how much should be used,

when it should not be used,

and which ecological conditions affect its availability.

That is a complex knowledge system.

The 2026 Mount Elgon research illustrates this beautifully: local experts did not simply name plants. They described unusual feeding patterns, preparation behaviours, seasonal targeting, animal health contexts and observations involving mothers and calves.

Such information is scientifically valuable.

It is also culturally valuable.

Therefore, documentation must involve informed consent, appropriate attribution, community participation, benefit sharing and protection against inappropriate disclosure or commercialization.

The goal should be partnership rather than extraction.

From forest observation to laboratory science

What happens when a plant repeatedly appears in animal medicinal behaviour?

A serious research program should move through several stages.

First comes behavioural documentation.

Researchers record the animal, plant, context, season, health status, frequency, plant part and unusual aspects of consumption.

Then comes botanical identification.

The species must be correctly identified and ideally supported by voucher specimens.

Next comes ecological investigation.

Is the plant normally abundant in the animal's diet? Is the behaviour seasonal? Do healthy animals use it? Do sick animals use it more frequently?

Then comes chemical analysis.

Researchers investigate the compounds present in the relevant plant part and preparation.

Next comes biological testing.

Potential antiparasitic, antimicrobial, anti-inflammatory, antioxidant or other activities can be investigated using appropriate laboratory models.

Then comes toxicology and pharmacology.

A substance that kills a parasite may also damage the host.

Finally, if a genuine therapeutic candidate emerges, much more extensive biomedical development is required.

The journey from elephant behaviour to human medicine is therefore not a shortcut.

It is a research pathway.

What counts as convincing evidence?

Because zoopharmacognosy can easily become sensationalized, evidence standards are crucial.

The strongest evidence combines several dimensions.

A behavioural signal becomes more interesting when the animal targets a substance unusually, especially during a defined physiological challenge. Chemical evidence becomes stronger when the substance contains biologically active compounds. Laboratory evidence becomes more meaningful when the activity occurs at concentrations plausibly encountered by the animal. Ecological evidence matters when the behaviour is repeated across individuals or populations. Finally, physiological or fitness benefits provide the strongest test of whether the behaviour actually functions as medication.

This suggests a hierarchy of confidence:

unusual consumption → repeated behavioural association → ecological context → chemical activity → physiological effect → demonstrated health benefit

Not every study will reach the final stage.

That is normal.

Science advances by distinguishing hypotheses from established mechanisms.

The word “putative” is therefore scientifically useful.

It means: this is a credible possibility supported by evidence, but it still requires further testing.

Technology is opening a new window into animal medicine

The future of zoopharmacognosy will not rely only on human observation.

Camera traps can record rare behaviours.

GPS collars can reveal long-distance movements toward particular habitats.

Drones can map resource availability.

Remote sensing can track vegetation changes.

Environmental DNA can help characterize biological communities.

Metabolomics can reveal chemical fingerprints.

Genomics can help investigate how animals perceive and metabolize plant compounds.

Microbiome analysis can examine interactions between medicinal foods and gut microorganisms.

Artificial intelligence can assist in detecting unusual feeding patterns in enormous volumes of camera-trap or movement data.

Together, these technologies could transform zoopharmacognosy from a collection of fascinating observations into a more quantitative science.

Imagine being able to compare an elephant's movement before, during and after illness.

Imagine detecting a sudden change in plant selection.

Imagine matching that behaviour with the chemical profile of the selected plant.

Imagine measuring parasite load before and after the behavioural episode.

That would move the field much closer to demonstrating cause and effect.

A new conservation concept: protect the pharmacy corridors

Conservation planning traditionally asks:

Where does the species live?

Zoopharmacognosy encourages another question:

What resources does the species need access to throughout its life?

A medicinal plant might occur outside a protected area.

A mineral-rich cave might lie several kilometres from the main forest.

A seasonal herb might appear only after monsoon rains.

A particular tree might grow along a wildlife movement route.

A medicinal resource may therefore exist outside the boundaries of conventional protected-area management.

This suggests a useful conservation concept:

pharmacy corridors, connected landscapes that preserve animals' access to diverse ecological resources, including potentially medicinal ones.

The concept does not require assuming that every plant is medicinal.

It simply recognizes that animals may need landscape-scale access to a diversity of resources whose functions are not yet completely understood.

Biodiversity has economic value we have barely begun to measure

There is also an economic argument.

Biodiversity provides ecosystem services that are difficult to replace.

Medicinal resources represent one component.

Natural-product discovery can generate pharmaceuticals, veterinary products, nutraceuticals, agricultural compounds, cosmetics and biotechnology applications.

But assigning a simple price to biodiversity is dangerous because the economic value of an unknown resource is inherently difficult to calculate.

A plant that has no current commercial value may contain a molecule whose significance is discovered decades later.

This creates an option value of biodiversity.

Preserving an ecosystem preserves future possibilities.

Destroying it permanently eliminates them.

The economic logic therefore resembles an investment decision under uncertainty.

We may not know which species will become valuable.

But once a species is extinct, its potential cannot be recovered.

This is one reason the economic case for conservation should not be limited to the market value of known resources.

The unknown has value too.

Bioprospecting without biopiracy

The search for useful biological compounds is often called bioprospecting.

Done responsibly, it can support conservation and scientific discovery.

Done irresponsibly, it can become biopiracy, where biological resources or traditional knowledge are appropriated without adequate recognition, consent or benefit sharing.

The difference is not simply whether a researcher discovers something useful.

It is how the discovery is made and who benefits from it.

A future zoopharmacognosy project in India should therefore involve biodiversity authorities, scientists, local communities, Indigenous knowledge holders, veterinarians, conservation organizations and legal/ethical experts from the beginning.

Benefit sharing should not be an afterthought added once a commercial product appears.

It should be built into the research architecture.

The conservation value of “unknown”

Conservation arguments often focus on what we already know.

We protect a tiger because we know the tiger exists.

We protect a medicinal plant because we know it has medicinal value.

But zoopharmacognosy reveals a different reason to protect biodiversity:

we may not yet know what it contains.

There may be plants whose chemical profiles have never been studied.

There may be insects with unexplored antimicrobial compounds.

There may be fungi producing molecules unknown to science.

There may be animal behaviours that have never been documented.

There may be ecological relationships that disappear before researchers even recognize them.

This is the value of the unknown.

Biodiversity is not merely a catalogue of known species.

It is a reservoir of possibilities.

A forest can lose knowledge before it loses species

Consider a hypothetical medicinal plant that remains common enough to survive.

But the elephants that once used it disappear.

The older generation of local knowledge holders dies.

The traditional harvesting practice is abandoned.

The plant becomes scientifically obscure.

The ecological relationship disappears even though the species remains.

This is a subtler form of biodiversity loss.

We might call it relational extinction: the disappearance of an ecological or cultural relationship without necessarily requiring the immediate extinction of the species itself.

A plant can survive while its relationship with an animal disappears.

An animal can survive while knowledge of a resource disappears.

A community can retain a plant while losing the cultural context surrounding its use.

Conservation therefore needs to think not only about organisms, but about relationships.

One Health: the larger picture

Zoopharmacognosy naturally fits within a One Health framework because the health of animals, humans and ecosystems is interconnected.

A degraded ecosystem can alter wildlife health.

Changes in wildlife health can affect disease dynamics.

Loss of plant diversity can reduce ecological resilience.

Loss of traditional knowledge can reduce cultural and medicinal options.

Changes in livestock management can influence parasite resistance.

Climate change can affect all of these simultaneously.

The forest pharmacy is therefore not an isolated biological curiosity.

It is part of a larger system linking:

biodiversity → animal health → ecosystem health → human health

This is also why the destruction of habitats should not be evaluated only in terms of carbon, timber or land area.

A forest is a health-supporting system.

Planetary health begins with ecological relationships

The same argument extends into planetary health.

Human societies increasingly depend on simplified landscapes.

Monocultures replace diverse vegetation.

Urbanization fragments habitats.

Climate change shifts species distributions.

Pollution alters soil and water chemistry.

Overharvesting removes biological resources.

Each pressure can reduce the number of choices available to wildlife.

And choice matters.

An animal with access to only a few plant species has fewer nutritional and chemical options than an animal living in a diverse ecosystem.

Recent research on herbivores emphasizes the importance of phytochemical diversity and suggests that diverse plant communities can provide animals with broader chemical options relevant to health.

Biodiversity is therefore not simply an aesthetic luxury.

It can be part of the physiological environment in which animals maintain health.

The pharmacy is also a classroom

Perhaps the most profound lesson of zoopharmacognosy is that animals can teach us how ecosystems work.

They reveal relationships that conventional surveys may miss.

A botanist might ask:

What species are present?

An ecologist might ask:

How are species interacting?

A pharmacologist might ask:

Which molecules are biologically active?

A veterinarian might ask:

Does this behaviour correspond to illness or recovery?

An Indigenous knowledge holder might ask:

How has this plant been understood and used across generations?

Zoopharmacognosy brings these questions together.

The animal becomes the observer.

The forest becomes the experimental environment.

Science becomes the process of interpreting the interaction.

What conservation should look like in the age of the forest pharmacy

If the forest is a living health system, conservation strategies should become more sophisticated.

Protecting charismatic animals remains essential.

But conservation should also preserve the diversity of plants they encounter.

It should maintain seasonal resource availability.

It should protect mineral and soil resources where ecologically important.

It should maintain movement corridors.

It should conserve older social animals that may carry behavioural knowledge.

It should monitor climate-driven changes in plant availability.

It should protect medicinal plants from unsustainable harvesting.

It should support Indigenous communities who have maintained ecological knowledge.

And it should encourage interdisciplinary research that links ecology, veterinary science, pharmacology, ethnobotany and conservation biology.

The goal is not to turn forests into pharmaceutical factories.

The goal is to keep ecosystems functioning well enough that their biological relationships continue to exist.

The future research agenda

The next generation of zoopharmacognosy research could move in several interconnected directions.

Long-term wildlife studies could follow individuals throughout their lives, documenting illness, diet, movement and recovery.

Chemical ecology could identify which plant compounds are associated with unusual animal choices.

Veterinary science could investigate whether naturally occurring compounds have practical applications in animal health.

Pharmacology could screen candidate compounds for antimicrobial, antiparasitic, anti-inflammatory or other biological activities.

Microbiome research could examine how medicinal foods alter gut microbial communities.

Indigenous knowledge partnerships could identify culturally significant plants and ecological indicators while ensuring ethical governance.

Conservation science could map medicinal-resource landscapes and identify areas where habitat fragmentation threatens access.

Climate research could investigate whether changing seasons disrupt animal-resource relationships.

Economists could attempt to estimate the option value of conserving unexplored biological diversity.

Policy researchers could strengthen access-and-benefit-sharing mechanisms so that discoveries do not separate communities from the benefits of knowledge they helped preserve.

And artificial intelligence could integrate enormous datasets that humans cannot easily analyze alone.

The result could be a new science of ecological medicine, one that does not begin in a laboratory and end in a forest, but moves in both directions.

What we must not lose

There is a temptation to look at zoopharmacognosy and see only the possibility of discovering new drugs.

That would be too narrow.

The real value is larger.

It is the recognition that ecosystems contain relationships we have not fully understood.

A medicinal plant is not merely a chemical container.

It is part of a food web.

An elephant is not merely a consumer.

It is a carrier of ecological memory.

An Indigenous knowledge holder is not merely an informant.

They may be part of a living knowledge tradition.

A forest is not merely an area of vegetation.

It is an interconnected system of biological information.

When habitat disappears, all of these dimensions can be damaged simultaneously.

The forest pharmacy has no shelves

Imagine standing in an ancient forest.

There are no white-coated pharmacists.

No medicine cabinets.

No labels.

No standardized bottles.

Yet animals move through the landscape making choices.

They smell.

They taste.

They remember.

They observe.

They learn.

They avoid.

They return.

Sometimes they choose ordinary food.

Sometimes they choose something bitter.

Sometimes something toxic.

Sometimes a plant they rarely touch.

Sometimes soil.

Sometimes bark.

Sometimes an insect.

And sometimes those choices may correspond to an internal biological need.

We are only beginning to understand what those choices mean.

That uncertainty is not a reason to dismiss the phenomenon.

It is a reason to study it carefully.

Conservation is also the protection of knowledge

The deepest lesson of zoopharmacognosy may therefore be this:

Conservation is not only about saving what we know. It is about protecting what we have not yet learned.

A species may contain a molecule science has never characterized.

A forest may contain a plant whose medicinal potential remains unknown.

An elephant herd may carry behavioural knowledge that has never been documented.

An Indigenous community may preserve ecological information that has never entered a scientific database.

A soil microorganism may produce a compound that could eventually become medically valuable.

We do not know which pieces of biodiversity will matter most in the future.

That is precisely why losing them is so dangerous.

The final prescription: protect the ecosystem, not just the ingredient

It is easy to imagine conservation becoming a search for “the medicinal plant.”

But the real object of protection is much larger.

The plant needs its soil.

The soil needs its microorganisms.

The plant needs pollinators and seed dispersers.

The animal needs access to the plant.

The animal needs a functioning landscape.

The community needs access to its knowledge and resources.

Researchers need ethical partnerships.

And future discoveries need intact ecosystems in which they can still be found.

The forest pharmacy therefore cannot be conserved by putting one plant behind a fence.

It must be conserved as a living system.

That means protecting habitats, ecological connectivity, biodiversity, traditional knowledge, animal populations, seasonal processes and the relationships connecting them.

The greatest medicinal resource in nature may not be a particular plant at all.

It may be biodiversity itself.

Because biodiversity is what creates the enormous chemical, behavioural and ecological diversity from which future discoveries emerge.

The forest pharmacy has no walls.

Its medicines are alive.

Its catalogue is biodiversity.

Its pharmacists are sometimes animals.

Its knowledge is distributed among species, landscapes and cultures.

And once a species, behaviour or ecological relationship disappears, there may be no way to restock the shelf.

That is why protecting forests is not only about preserving scenery.

It is about preserving possibilities.

Possibilities for wildlife.

Possibilities for science.

Possibilities for medicine.

Possibilities for traditional knowledge.

And possibilities for a future in which humanity may still learn from the oldest pharmacy on Earth.

"The forest does not merely contain medicine.

The forest is the medicine system."

And perhaps the most important prescription it gives us is the simplest:

Protect the living library before the pages are gone.